Search Results

December 2021 "Ottawa, Ontario, Canada, Nov. 30, 2021 -- Orion Biotechnology, a clinical stage company

June 2022 "Ottawa, Canada, May 10, 2022 — Orion Biotechnology Canada Ltd, a drug discovery and development Oliver Hartley, Orion’s Vice-President Drug Discovery, will present Orion’s novel technology for targeting His presentations will describe Orion’s drug discovery platform, one of the fastest drug discovery solutions Hartley will also present new data on Orion’s CCR2 antagonist, OB-004, demonstrating the ability of this

July 2022 "Orion Biotechnology and Peptilogics are pursuing AI-driven drug discovery to explore new functional

Development The pathway of opioid drugs into cellular structures Inversago Pharma will present at BBHIC 2023 Orion Biotechnology attended the Swiss Biotech Day Addex Therapeutics attended the Swiss Biotech Day Sosei

To solve this industry-wide problem, Orion Biotechnology (Orion) is introducing a novel solution driven Orion’s PROcisionXᵀᴹ Platform In Orion’s discovery process, shape space at the TM domain ‘message’ site Figure 2: Workflow in Orion’s PROcisionXᵀᴹ platform. About Orion Biotechnology Orion’s mission is to unlock the therapeutic potential of previously undruggable For more information, follow Orion Biotechnology on LinkedIn or visit www.orionbiotechnology.com.

Orion Biotechnology Completes Discovery of First-in-Class Molecule Against Undrugged GPCR Target in Four

Industry News Orion Biotechnology at the AACR 2023.

chemokine receptor 3 Industry News New cannabinoid CB1 receptor antagonists disclosed in Inversago patent Orion Biotechnology will be attending BIO 2024 Antiverse is attending BIO 2024 Septerna to Present Preclinical

Initiates Clinical Study to Further Evaluate Functional Precision Medicine Platform in Cancer Patients Orion Biotechnology to Showcase GPCR Progress at 2024 OBIO Investment Summit BioAge raises $170M as obesity

Machine Learning Model Three GPCR Companies Earn Prestigious Best Places to Work Certification in 2023 Orion Biotechnology will be presenting at the OBIO 2024 Investment Summit X-rays to AlphaFold: the future

Inês Pinheiro and Oliver Hartley from the Orion Biotechnology team on their recent study on Arylsulfatases

Industry News Orion Biotechnology will be participating in a panel discussion at the LSX World Congress

, Last Visit in its clinical phase 2b trial with AEF0117 for the treatment of cannabis use disorder Orion Biotechnology will be presenting at the 19th Biopharma Drug Discovery Nexus Salipro Biotech will participate

Aequorin: superior choice for GPCR calcium signalling GPCR: Structural Insights and Role in Drug Discovery Orion Biotechnology has a new website GPCR Events, Meetings, and Webinars November 25 - 26, 2024 | 6th International

Participate in Upcoming Investor and Industry Conferences Sosei and IPJ to become Nxera Pharma from April Orion Biotechnology will be at the BIO CEO & Investor Conference Salipro Biotech AB will be at the Oxford

Participate in Upcoming Investor and Industry Conferences International Day of Women and Girls in Science Orion Biotechnology Publishes Whitepaper Highlighting the Importance and Challenges in Unlocking “Undruggable

.- Jan Steyaert, scientific director of the VIB-VUB Center for Structural Biology, Vlaams Instituut Biotechnologie Brusle, Brussels, Belgium, has been named the winner of Brandeis’ 24th Jacob and Louise Gabbay Award in Biotechnology of one of the biggest classes of pharmaceutical targets by combining structural biology and advanced biotechnology

immunology #antibodies #medicine #cancer #innovation #gpcr #synabs #monoclonalantibodies #drugdiscovery #biotechnology

, and more Illuminating the druggable genome: Pathways to progress Industry News Anatole Klepatsky, Orion's

July 19, 2022 07:00 AM Eastern Daylight Time BOSTON--Tectonic Therapeutic, Inc. a pre-clinical stage biotechnology

Melissa Faris as Chief Business Officer Septerna: Revitalizing G-Protein Coupled Receptor Drug Discovery Orion

than three decades of experience leading sales and marketing operations for both global and domestic biotechnology

December 2021 "Early-stage studies of COVID-19 treatments from the likes of Vir Biotechnology Inc. and

., an independently operated, new biotechnology company to develop and commercialize an antibody, discovered

GPCR Jobs Biotechnology and Biological Sciences Doctoral Training Programme Senior QM Manager Director

GPCR Jobs Biotechnology and Biological Sciences Doctoral Training Programme Senior QM Manager Director

Trends in Biotechnology , 29 (9), 435–442. https://doi.org/10.1016/j.tibtech.2011.04.003 Fowler, D.